China (Mainland)
Premiumsupplier
Rheumatoid arthritis medications Tofacitinib CAS NO.477600-75-2
- Min.Order: 1 Gram
- Payment Terms: T/T,MoneyGram
- Product Details
Keywords
- Tofacitinib
- Tofacitinib powder
- cas 477600-75-2
Quick Details
- ProName: Rheumatoid arthritis medications Tofac...
- CasNo: 477600-75-2
- Molecular Formula: C16H20N6O
- Appearance: white powder
- Application: used for the treatment of rheumatoid a...
- DeliveryTime: within 3 working days upon payment
- PackAge: aluminum foil bag, discreet packing
- Port: HK, Shanghai, Shenzhen
- ProductionCapacity: 1 Kilogram/Month
- Purity: 99%
- Storage: cool and dry place
- Transportation: email: wonda-chem@outlook.com
- LimitNum: 1 Gram
Superiority
1.high quality:
quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.
2.reasonable price:
we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.
3.low moq:
no worry about the low moq, our moq is 1 gram or even lower.
4.good service.
fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.
5. fast shipping and secure courier.
we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.
Details
Rheumatoid arthritis medications Tofacitinib
Specification
Tofacitinib
CAS NO. 477600-75-2
C16H20N6O
rheumatoid arthritis medications
COA
|
Product Name |
Tofacitinib |
||||||
|
Synonyms |
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile;CP 690550;3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo(2,3-D)pyrimidin-4-yl-, (3R,4R)-; CP-690550(Tasocitinib,CP690550);CP 690550(Tasocitinib); Tasocitinib; 3-((3R,4R)-4-Methyl-3-(Me...;Tasocitinib (CP 690550) |
||||||
|
CAS |
477600-75-2 |
||||||
|
Molecular formula |
C16H20N6O |
||||||
|
Molecular Weight |
312.3696 |
||||||
|
Molecular Structure |
|||||||
|
Physical and Chemical Properties |
|
||||||
|
General Description |
Light yellow powder |
||||||
|
Usage |
Tofacitinib is used for the treatment of rheumatoid arthritis (RA), and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases. Also Tofacitinib is used for the prevention of organ transplant rejection. |
||||||
|
Packing |
25kg/drum |
||||||
|
Storage condition |
Tasocitinib should be stored in a well-closed container at low temperature, keep away from moisture, heat and light. |
||||||
|
Specifications |
|||||||
|
Items |
Standard |
||||||
|
Appearance |
Light yellow powder |
||||||
|
Loss on drying |
≤0.2% |
||||||
|
Watere content(KF) |
≤0.2% |
||||||
|
Purity(by HPLC) |
NLT 98.0% |
||||||
|
NMR Spectrum |
Sample correspond to that of standard preparation |
||||||
|
Mass Spectrum |
312.37±0.5Da |
||||||
|
English Name |
CAS |
|
Dasatinib |
302962-49-8 |
|
Dasatinib monohydrate |
863127-77-9 |
|
Nilotinib |
641571-10-0 |
|
Nilotinib hydrochloride monohydrate |
923288-90-8 |
|
Ponatinib |
943319-70-8 |
|
Sorafenib |
284461-73-0 |
|
Sorafenib tosylate |
475207-59-1 |
|
Pomalidomide |
19171-19-8 |
|
Lapatinib |
231277-92-2 |
|
Lapatinib ditosylate |
388082-78-8 |
|
Nitisinone |
104206-65-7 |
|
Tofacitinib citrate |
540737-29-9 |
|
Pazopanib |
444731-52-6 |
|
Pazopanib hydrochloride |
635702-64-6 |
|
Osimertinib AZD9291 |
1421373-65-0 |
|
Osimertinib Mesylate(AZD9291) |
1421373-66-1 |
|
Trametinib |
871700-17-3 |
|
3-cycloproppyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione |
871700-24-2 |
|
3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(methylamino)-2,4(1H,3H )-pyrimidinedione |
871700-22-0 |
|
N-(3-{[3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7 -trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl]amino}ph enyl)acetamide |
871700-25-3 |
|
3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl 4-methylbenzenesulfonate |
871700-32-2 |
|
Bosentan |
147536-97-8 |
|
Lenalidomide |
191732-72-6 |
|
3-Methyl-6-nitro-1H-indazole |
6494-19-5 |
|
2,3-dimethyl-6-nitroindazole |
444731-73-1 |
|
2,3-dimethyl-2H-indazol-6-amine |
444731-72-0 |
|
2,3-dimethylindazol-6-amine HCl |
635702-60-2 |
|
N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine |
444731-74-2 |
|
2,3-dimethyl-2H-indazol-6-amine hydrochloride |
635702-60-2 |
|
Masitinib |
790299-79-5 |
|
2-bromo-1-pyridin-3-ylethanone hydrobromide |
17694-68-7 |
|
N-(2-Methyl-5-nitrophenyl)-4-(3-pyridinyl)-2-thiazolamine |
1048007-94-8 |
|
N-(2-methyl-5-nitrophenyl)-4-pyridin-3-yl-1,3-thiazol-2-amine |
1048007-94-8 |
|
Sorafenib tosylate |
475207-59-1 |
|
Erlotinib hydrochloride |
183319-69-9 |
|
Gefitinib |
184475-35-2 |
|
INCB28060 |
1029712-80-8 |
|
Cabozantinib L-Malate |
1140909-48-3 |
|
LDK378 |
1032900-25-6 |
|
Ceritinib dihydrochloride |
1380575-43-8 |
|
alectinib |
1256580-46-7 |
|
Lapatinib ditosylate |
388082-78-8 |
|
Crizotinib |
877399-52-5 |
|
Sunitinib Malate |
341031-54-7 |
|
Venetoclax |
1257044-40-8 |
|
Selumetinib |
606143-52-6 |
|
AZD3759 |
1626387-80-1 |
|
EAI045 |
1942114-09-1 |
|
Baricitinib |
1187594-09-7 |
|
Dovitinib |
915769-50-5 |
|
Regorafenib |
755037-03-7 |
|
Nintedanib |
656247-17-5 |
|
Nintedanib Ethanesulfonate Salt |
656247-18-6 |
|
Nintedanib |
656247-17-5 |
|
Lenvatinib |
417716-92-8 |
|
lenvatinib mesylate |
857890-39-2 |
|
PCI-32765 |
936563-96-1 |
|
Abemaciclib |
1231929-97-7 |
|
AP26113 |
1197958-12-5 |
|
Aptinib |
811803-05-1 |
|
Anlotinib |
1058156-90-3 |
|
AZD1775 |
955365-80-7 |
Packing and shipping
